Lymphoproliferative disorders caused by mutations in BIRC4 or SHD21A are associated with an increased sensitivity to Epstein–Barr virus (EBV) infection, often leading to the development of HLH [13]. This evidence concerns the gene XIAP and hemophagocytic syndrome.